Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Syndrome MDS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06692894
What this trial is testing

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes, Adult
University of Vermont 30
Not applicableUnknownNCT02779569
What this trial is testing

A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes (MDS)
The First Affiliated Hospital with Nanjing Medical University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06566742
What this trial is testing

Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaClonal Cytopenia of Undetermined Significance
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT03318159
What this trial is testing

Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients

Who this might be right for
Aplastic AnemiaMyelodysplastic SyndromesFungal Infection
Seoul National University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Not applicableActive Not RecruitingNCT07413679
What this trial is testing

Long-term Safety of Danicopan: IPIG Registry-based Cohort Study

Who this might be right for
Paroxysmal Nocturnal HemoglobinuriaPNH
Alexion Pharmaceuticals, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)Study completedNCT04827719
What this trial is testing

BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Groupe Francophone des Myelodysplasies 38
Not applicableEnded earlyNCT02291965
What this trial is testing

Blood Samples to Identify Biomarkers of Busulfan

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Fred Hutchinson Cancer Center 139
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)Study completedNCT02464657
What this trial is testing

Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Who this might be right for
LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 44
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00614523
What this trial is testing

Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
MDSMyelodysplastic SyndromesThrombocytopenia
Amgen 250
Testing effectiveness (Phase 2)Study completedNCT03397173
What this trial is testing

TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative NeoplasmAcute Myeloid Leukemia
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT00006220
What this trial is testing

Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Washington University School of Medicine 5
Not applicableStudy completedNCT00569842
What this trial is testing

Investigation of the Cylex® ImmuKnow® Assay

Who this might be right for
LeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia+6 more
Indiana University 45
Testing effectiveness (Phase 2)Study completedNCT00003960
What this trial is testing

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Early research (Phase 1)Temporarily pausedNCT06888323
What this trial is testing

Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment

Who this might be right for
Refractory Myelodysplastic Syndrome
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Testing effectiveness (Phase 2)Looking for participantsNCT06892223
What this trial is testing

Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

Who this might be right for
Acute Myeloid LeukaemiaMDS (Myelodysplastic Syndrome)MPN (Myeloproliferative Neoplasms)
Istituto Clinico Humanitas 42
Next Page